News
QUCY
0.4569
-8.95%
-0.0449
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 8h ago
Quantum Cyber N.V. completes major financing and governance overhaul
TipRanks · 1d ago
Weekly Report: what happened at QUCY last week (0420-0424)?
Weekly Report · 2d ago
Weekly Report: what happened at QUCY last week (0413-0417)?
Weekly Report · 04/20 09:13
Quantum Cyber Divests ColoAlert IP, Refocuses on Pancreatic Screening
TipRanks · 04/15 21:50
Weekly Report: what happened at QUCY last week (0406-0410)?
Weekly Report · 04/13 09:14
Weekly Report: what happened at QUCY last week (0330-0403)?
Weekly Report · 04/06 09:14
Weekly Report: what happened at QUCY last week (0323-0327)?
Weekly Report · 03/30 09:14
Mainz Biomed Receives Nasdaq Notice on Bid Price
TipRanks · 03/25 21:14
Weekly Report: what happened at QUCY last week (0316-0320)?
Weekly Report · 03/23 09:14
Quantum Leap: Sealsq to integrate post-quantum cryptography in drone technology
TipRanks · 03/18 19:35
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 03/17 17:05
Quantum Cyber Aligns Strategy With U.S. Cyber Priorities
TipRanks · 03/17 13:02
Quantum Cyber says shareholder David Lazar pre-funds additional tranche
TipRanks · 03/17 12:41
Quantum Cyber Aligns Company Strategy With Trump Administration's National Cybersecurity Strategy
Benzinga · 03/17 12:34
Quantum Cyber Aligns Strategy With Trump Administration's National Cyber Security Framework, Targets Acquisitions in Quantum and Cyber Defense Sectors
Barchart · 03/17 07:30
Weekly Report: what happened at QUCY last week (0309-0313)?
Weekly Report · 03/16 09:13
Mainz Biomed changes ticker symbol to "QUCY"
Seeking Alpha · 03/13 11:55
Mainz Biomed Rebrands As Quantum Cyber; Ticker Shifts To QUCY On Nasdaq
Benzinga · 03/13 11:33
Quantum Cyber (f/k/a Mainz Biomed) Announces Stock Ticker Symbol Change to NASDAQ: QUCY
Barchart · 03/13 06:30
More
Webull provides a variety of real-time QUCY stock news. You can receive the latest news about Mainz Biomed NV through multiple platforms. This information may help you make smarter investment decisions.
About QUCY
Mainz Biomed N.V. is a Germany based molecular genetics cancer diagnostic company. The Company operates under one segment, namely genetic diagnostic testing services. Its portfolio consists of various products and product candidates, such as ColoAlert, a colorectal cancer (CRC) screening stool-based DNA (deoxyribonucleic acid) test; PancAlert, a stool-based screening test for the detection of pancreatic cancer; GenoStrip, a platform technology to detect pathogens in environments on a molecular genetic basis. The Company competes with Exact Sciences, Epigenomics AG, Novigenix SA, GRAIL, Inc. and Agena Biosciences Inc.